Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma

Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma

10.2122/gbc.2012.0251

Saved in:
Bibliographic Details
Main Author: Ku, C.-S.
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Review
Published: 2014
Online Access:http://scholarbank.nus.edu.sg/handle/10635/116896
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-116896
record_format dspace
spelling sg-nus-scholar.10635-1168962015-01-06T13:45:34Z Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma Ku, C.-S. CANCER SCIENCE INSTITUTE OF SINGAPORE 10.2122/gbc.2012.0251 Gastric and Breast Cancer 11 4 208-210 2014-12-12T07:55:26Z 2014-12-12T07:55:26Z 2012-10 Review Ku, C.-S. (2012-10). Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma. Gastric and Breast Cancer 11 (4) : 208-210. ScholarBank@NUS Repository. <a href="https://doi.org/10.2122/gbc.2012.0251" target="_blank">https://doi.org/10.2122/gbc.2012.0251</a> 11097655 http://scholarbank.nus.edu.sg/handle/10635/116896 NOT_IN_WOS Scopus
institution National University of Singapore
building NUS Library
country Singapore
collection ScholarBank@NUS
description 10.2122/gbc.2012.0251
author2 CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet CANCER SCIENCE INSTITUTE OF SINGAPORE
Ku, C.-S.
format Review
author Ku, C.-S.
spellingShingle Ku, C.-S.
Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma
author_sort Ku, C.-S.
title Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma
title_short Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma
title_full Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma
title_fullStr Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma
title_full_unstemmed Trametinib plus dabrafenib: Targeting RAS-MAPK pathway for BRAF V600-mutant melanoma
title_sort trametinib plus dabrafenib: targeting ras-mapk pathway for braf v600-mutant melanoma
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/116896
_version_ 1681095248709681152

Similar Items